WANG, WEI

Release date:2016-05-17  Release:

WANG, WEI

Associate Professor of Pharmaceutics

School of Pharmacy

Phone: 86-25-83271102

Email: wangcpu209@cpu.edu.cn

Research Summary

Professor WANG’s research focuses on the the studies of nanovector based delivery system for biomacromolecular drugs and nanoscale targeted drug delivery system. He recently published a paper entitled "A dual-targeting drug co-delivery system for tumor chemo- and gene combined therapy", which considered that combining DCA and p53 gene could be an effective way to treat tumors and developed a DSPE-PEG-AA modified reconstituted high-density lipoprotein-based DCA/p53-loaded nanoparticles, which are fabricated as a drug/gene dual-targeting co-delivery system for potential cancer therapy.

Education

2009   Ph.D., Pharmaceutics, China Pharmaceutical University

2006   M.S., Pharmacology, China Pharmaceutical University

2003   B.S., Pharmacy, China Pharmaceutical University

Academic Experience

2014-2015  Visiting Scholar of Pharmaceutics, University of North Carolina at Chapel Hill (UNC)

2012- Associate Professor of Pharmaceutics, China Pharmaceutical University

2009-2012  Lecturer of Pharmaceutics, China Pharmaceutical University

Awards and Honors

2014  The Youth Pharmaceutical Scientist Award, Chinese Pharmaceutical Association (CPA)

2013  The Chief Expert, Jiangsu Association for Science and Technology (JAST)

2012 The Drug Pricing Evaluation Expert, National Development and Reform Commission (NDRC)

Publications

1. Xuefang Ding1, Wei Wang1, Yazhe Wang, et al. A versatile reticular polyethyleneimine derivative-mediated targeted drug and gene co-delivery for tumor therapy. Mol Pharm, 2014, 11(10):3307-21.

2. Xiuli Bao1, Wei Wang1, Cheng Wang, et al. A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy. Biomaterials, 2014, 35 (29): 8450-8466.

3. Yang Ding1, Wei Wang1, *, Meiqing Feng, et al. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy. Biomaterials, 2012, 33 (34): 8893-8905.